Patent Application for Whitening Cosmetic Composition with Artemisinic Acid

ChangeBridge: Patent Apps - Pharma (A61K)

Detected March 26th, 2026

Summary

The USPTO has published a patent application (US20260083657A1) for a whitening cosmetic composition containing artemisinic acid, nicotinamide, and/or glutathione. The application, filed by Yunnan Botanee Bio-Technology Group Co., Ltd., describes a formulation designed to inhibit melanin production and reduce skin irritation.

View original document View source feed page

What changed

This document is a published patent application, not a regulatory rule or guidance. It details a novel cosmetic composition intended for skin whitening, featuring artemisinic acid combined with nicotinamide and/or glutathione. The inventors claim this formulation enhances melanin inhibition, improves the solubility of artemisinic acid, and reduces local skin irritation, aiming for synergistic whitening effects and better skin absorption.

As a patent application, it does not impose immediate regulatory obligations. However, it signifies potential future product development and market entry in the cosmetics sector. Companies involved in cosmetic manufacturing, particularly those focusing on skin lightening products, should be aware of this filing as it may indicate emerging technologies or competitive intellectual property in the field.

Source document (simplified)

← USPTO Patent Applications

COMPOSITION WITH WHITENING EFFECT AND APPLICATION THEREOF IN COSMETICS

Application US20260083657A1 Kind: A1 Mar 26, 2026

Assignee

Yunnan Botanee Bio-Technology Group Co., Ltd.

Inventors

Yichun WANG, Feifei WANG, Liping QU, Yanzhen SHEN, Zuding WANG, Qiongfen WU, Lijuan YAN, Zhaoxiang YANG, Xiao MA, Zhenyu GUO

Abstract

A composition with a whitening effect includes artemisinic acid, and further includes nicotinamide and/or glutathione. The artemisinic acid is creatively compounded with the nicotinamide and/or the glutathione to inhibit generation or transfer of melanin in all directions at multiple angles through different approaches or mechanisms. The composition can significantly inhibit activity of tyrosinase and inhibit production of the melanin, and various active ingredients are complemented with each other to achieve a synergistic effect. Meanwhile, the composition can also enhance water solubility of the artemisinic acid and reduce local irritant toxicity caused by insolubility of the artemisinic acid to enable the artemisinic acid to have good water solubility and low local irritant toxicity while achieving the whitening effect, thereby promoting deep absorption by the skin.